Quarterly report pursuant to Section 13 or 15(d)

Accrued Expenses (Tables)

v3.10.0.1
Accrued Expenses (Tables)
 9 Months Ended
Sep. 30, 2018
Accrued Expenses  
Schedule of accrued expenses

Accrued expenses consisted of the following as of September 30, 2018 and December 31, 2017 (in thousands):

 

 

 

 

 

 

 

 

 

 

    

September 30, 2018

    

December 31, 2017

 

External research and preclinical development

 

$

7,910

 

$

5,875

 

Employee compensation and benefits

 

 

2,461

 

 

2,494

 

Professional fees

 

 

695

 

 

1,225

 

Facilities and other

 

 

93

 

 

134

 

 

 

$

11,159

 

$

9,728